Navigation Links
Hydrophilic ProteinChip Arrays from Ciphergen

ProductsHydrophilic ProteinChip Arrays from Ciphergen
Company Ciphergen
Item Hydrophilic ProteinChip Arrays
Price 
Description Ciphergen's ProteinChip arrays have been developed for affinity capture of proteins from biological samples. A variety of ProteinChip chemical surfaces allow differential capture of proteins according to their unique biochemical properties. Each chip has eight different spots, allowing side-by-side sample comparison, and the chips are color-coded with a unique hydrophobic coating. Ciphergen's proprietary chip technology thus allows the researcher to rapidly capture, purify and characterize proteins directly on the chip.
Hydrophilic arrays bind proteins through electrostatic and dipole-dipole interactions as well as hydrogen binding. Proteins with hydrophilic and charged surface animo acids such as serine, threonine and lysine bind well. Binding occurs in aqueous buffers with a water wash prior to analysis. ProteinChips NP1 and NP2: contain a SiO2 surface for general binding of proteins.
Info CiphergenCiphergen
Ciphergen Biosystems, Inc
6611 Dumbarton Circle
Fremont, CA 94555

Customer Service: 510-505-2188
Fax Number: (510) 505-2101
Web Site: http://www.ciphergen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. ProteinChip beta-amyloid multipeptide detection Kit from Ciphergen
2. ProteinChip Antibody Capture Kit from Ciphergen
3. Anion Exchange ProteinChip Arrays from Ciphergen
4. Immobilized Metal affinity ProteinChip Arrays from Ciphergen
5. Cation Exchange ProteinChip Arrays from Ciphergen
6. Hydrophobic ProteinChip Arrays from Ciphergen
7. ProteinChip System, Series 4000 from Ciphergen
8. PS20 and RS100 preactivated ProteinChip Arrays from Ciphergen
9. Multi - Organ Tissue - Arrays from Dominion Pharmakine S.L.
10. Apoptosis Pathway SpliceArrays from ExonHit Therapeutics Inc.
11. Custom Splice Arrays from ExonHit Therapeutics Inc.
...
Hygromycin resistance gene (hph), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
... The FRT-PGK-gb2-neo-FRT template is designed ... eukaryotic cells. The FRT-PGK-gb2-neo-FRT template encodes ... prokaryotic promoter (gb2) for expression of kanamycin ... eukaryotic promoter (PGK) for expression of neomycin ...
... is tailored to highly enrich ... of rat spleen cells. Cells ... (or compatible 0.5 Tesla) immunomagnetic ... CD4+ T cell content of ...
Biology Products:
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
Breaking Biology News(10 mins):
(Date:3/1/2017)... WA (PRWEB) , ... March 01, 2017 , ... ... research into the physiology of aging into clinical applications, announces the formation of ... proprietary oral-transmucosal dosage form of resveratrol, the drug which has been discussed in ...
(Date:2/28/2017)... Linda, Ca (PRWEB) , ... February 28, 2017 , ... ... molecular interactions. SPR is an optical phenomenon that is sensitive to changes in the ... resonance condition is affected by changes in refractive index occurring up to 300 nm ...
(Date:2/28/2017)... , Feb. 28, 2017  Phosphorus, a ... today the formation of the Phosphorus Scientific Advisory ... experts chosen to advise the company on the ... multi-site research initiatives. Please visit http://phosphorus.com/about-us/ ... initiatives. "We,ve gathered some of the ...
(Date:2/28/2017)... -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing ... diseases, asthma and allergic diseases and cancer, today ... full year ended December 31, 2016 and provided ... clinical highlights. "During 2016, we made ... starting five clinical trials across our XmAb portfolio.  ...
Breaking Biology Technology: